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Abstract
Background Prescribing errors are common. It has been
suggested that the severity as well as the frequency of
errors should be assessed when measuring prescribing error
rates. This would provide more clinically relevant infor-
mation, and allow more complete evaluation of the effec-
tiveness of interventions designed to reduce errors.
Objective The objective of this systematic review was to
describe the tools used to assess prescribing error severity
in studies reporting hospital prescribing error rates.
Data Sources The following databases were searched:
MEDLINE, EMBASE, International Pharmaceutical
Abstracts, and CINAHL (January 1985–January 2013).
Study Selection We included studies that reported the
detection and rate of prescribing errors in prescriptions for
adult and/or pediatric hospital inpatients, or elaborated on
the properties of severity assessment tools used by these
studies. Studies not published in English, or that evaluated
errors for only one disease or drug class, one route of
administration, or one type of prescribing error, were
excluded, as were letters and conference abstracts. One
reviewer screened all abstracts and obtained complete
articles. A second reviewer assessed 10 % of all abstracts
and complete articles to check reliability of the screening
process.
Appraisal Tools were appraised for country and method
of development, whether the tool assessed actual or
potential harm, levels of severity assessed, and results of
any validity and reliability studies.
Results Fifty-seven percent of 107 studies measuring
prescribing error rates included an assessment of severity.
Forty tools were identified that assessed severity, only two
of which had acceptable reliability and validity. In general,
little information was given on the method of development
or ease of use of the tools, although one tool required four
reviewers and was thus potentially time consuming.
Limitations The review was limited to studies written in
English. One of the review authors was also the author of
one of the tools, giving a potential source of bias.
Conclusion A wide range of severity assessment tools are
used in the literature. Developing a basis of comparison
between tools would potentially be helpful in comparing
findings across studies. There is a potential need to estab-
lish a less time-consuming method of measuring severity of
prescribing error, with acceptable international reliability
and validity.
1 Background
Prescribing errors are common in hospital inpatients. While
errors are under-reported in clinical practice, research
studies using methods other than spontaneous reporting
have found much higher rates. In a recent systematic
review of the prevalence, incidence, and nature of pre-
scribing errors in hospital inpatients (including a wider
range of methods for identifying errors), the median error
rates in 65 eligible studies were 7 % of medication orders,
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52 errors per 100 admissions, and 24 errors per 1,000
patient days [1]. Even errors that do not result in harm
create additional work and can adversely affect patients’
confidence in their care.
Tools for measuring errors are needed to evaluate the
effectiveness of interventions designed to reduce them.
Medication error rates are often used to compare drug dis-
tribution systems [2–4] and to assess the effects of inter-
ventions. However, medication errors range from those with
very serious consequences to those that have little or no
impact on the patient. It has thus been suggested that the
severity as well as the prevalence of errors should be taken
into account [5, 6]. Assessing the severity of errors detected
increases the clinical relevance of studies’ findings when
compared with studies based on prevalence alone. In their
systematic review of the prevalence, incidence, and nature
of prescribing errors in hospital inpatients, Lewis et al. [1]
noted that methods of classifying severity were disparate,
but did not discuss the tools identified.
In this study, our objective was to describe and evaluate
tools used to assess prescribing error severity in studies
reporting prescribing error rates in the hospital setting.
2 Methods
2.1 Search Strategy
We carried out a systematic review to identify the tools that
have been used to assess prescribing error severity in
hospitals, and to investigate the validation and reliability of
those tools. A recent comprehensive review of studies of
the prevalence of prescribing errors in hospitals up to the
end of 2007 was carried out by Lewis et al. [1]. We used
the results of this search but excluded conference abstracts
and letters [7] and those studies not assessing the severity
of error. SG then re-ran Lewis et al.’s search strategy to
identify additional papers published between 2008 and
January 2013 (inclusive). The following databases were
searched: MEDLINE, EMBASE, International Pharma-
ceutical Abstracts, and CINAHL using the keywords (error
OR medication error OR near miss OR preventable adverse
event) AND (prescription OR prescribe) AND (rate OR
incidence OR Prevalence OR epidemiology) AND (Inpa-
tient OR Hospital OR Hospitalization)—see Appendix for
full example. SG searched the reference list of any relevant
reviews identified and obtained the full text of any original
studies that potentially met our inclusion criteria. Finally,
SG hand-searched the reference lists of all included articles
and searched our research team’s local database of medi-
cation error studies in order to identify any further studies
informing the development, reliability, or validity of the
severity assessment tools identified.
2.2 Inclusion and Exclusion Criteria
2.2.1 Inclusion Criteria
Peer-reviewed studies that reported on the detection and
rate of prescribing errors in prescriptions for adult and/or
pediatric hospital inpatients, or elaborated on the properties
of severity tools used by these studies were included. All
study designs and lengths of follow-up were included. If
the same study was reported in multiple papers, all papers
were included.
2.2.2 Exclusion Criteria
The exclusion criteria were based on those of Lewis et al.
[1], with conference abstracts, letters, and studies not
measuring severity also excluded [7]:
• Studies not published in English.
• Letters.
• Conference abstracts.
• Studies neither reporting the incidence of prescribing
error separately from all types of medication error nor
reporting the reliability and validity of tools that have
been used to assess severity in these studies.
• Studies of errors for only one disease or drug class or
for one route of administration or one type of
prescribing error.
• Studies carried out in primary care or hospital
outpatients.
2.3 Screening and Data Extraction for Electronic
Search
All database search results were combined into a Reference
Manager 11 database. An electronic duplicate search was
conducted using Reference Manager 11 followed by a
manual duplicate search. All duplicate papers were
removed. SG then screened each title and abstract to
determine whether the full research paper should be
retrieved or whether it was evident it did not meet the
inclusion criteria at that stage. BDF independently screened
a random 10 % sample of abstracts to check the reliability
of the screening (agreement level 91 %). All discrepancies
were resolved through discussion. SG then reviewed all
retrieved full papers to determine whether the article met
the inclusion criteria and BDF independently reviewed a
random 10 % sample of full papers to check reliability
(agreement level 100 %). SG then extracted data from the
included articles regarding the tools used to assess pre-
scribing error severity. A second researcher (BDF) checked
the tables (but did not carry out a duplicate data extraction).
The following data were extracted directly into electronic
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tables: country and method of development, whether the
tool assessed actual or potential harm, levels of severity
assessed, and results of any validity and reliability studies.
We extracted any data referring to the reliability and
validity of the instruments rather than focusing on any
particular type of reliability or validity. Authors were not
contacted to provide further information. The data extrac-
ted were not amenable to meta-analysis; a descriptive
analysis was therefore conducted. We did not formally
assess the risk of bias.
3 Results and Discussion
3.1 Overview
Forty (62 %) of the 65 papers originally identified by
Lewis et al. [1] met our criteria. 210 abstracts were
screened during our additional electronic search and 67
full-text articles were obtained. Twenty of these papers met
our inclusion criteria; the rest were letters, conference
abstracts, or did not assess severity (Fig. 1). When com-
bined with the papers from Lewis et al. [1], a total of 60
papers were included [8–67] and 40 tools (including
adaptations of other tools) identified. Forty studies (67 %)
used original or adapted versions of four tools [11, 16, 68,
69], but there were also 18 tools designed for individual
studies. It is notable that 46 (44 %) of 104 studies mea-
suring the prevalence of prescribing errors in secondary
care did not include any assessment of severity. The
included tools and their properties are shown in Table 1 of
the Electronic Supplementary Material (ESM).
Methods of measuring severity were diverse, although
most tools had some features in common. The tools all
comprised single-item classification systems for error
severity with associated definitions. The majority were pre-
sented as ordinal Likert scales but one tool was based on a
visual analog scale [11]. Seven tools [24, 27, 48, 50–52, 68]
were a mixture of a severity assessment scale and another
type of assessment. For example, the NCC MERP (National
Coordinating Council for Medication Error Reporting and
Prevention) index [68] includes a category ‘not an error’. As
a consequence, the tool is a mixture of a severity assessment
scale and a tool for recording whether or not an error had
occurred. One study measured the predicted patient outcome
from clinical pharmacists’ recommendations made in
response to identified prescribing errors rather than the direct
clinical significance of the errors themselves [9].
3.2 Tool Development
Little information was given on the development of the
majority of tools (ESM Table 1). No information was
given at all for 19 (47.5 %) [9–12, 16–23, 34–39, 41–47,
57–60, 63, 64, 66, 67] of the 40 tools. For the other tools,
information was usually limited to statements explaining
that the tool was based on a previous one, the development
of which was not described or referenced. However, the
authors of two tools described the rationale or methodology
by which they adapted these previous tools. The NCC
MERP index was collapsed from nine to six categories by
Forrey et al. [48] because the original distinctions were
considered ambiguous or seemed similar. In a separate
study [31], an expert panel survey was used to adapt Folli
et al.’s tool [16]. Again, in neither case was the develop-
ment of the original tool described or referenced.
While many tools were developed for medication errors
in general, others were developed for studies of prescribing
error specifically. Tools were developed in a range of
countries (15 UK, 10 USA, 14 other, 1 not stated). Tools
developed for use in one country may not be transferable to
other countries, due to differences in healthcare systems.
3.3 Potential Versus Actual Harm
Thirty (75 %) tools were based on potential rather than
actual harm. It is of interest that the NCC MERP index [68]
was developed to assess actual harm but was subsequently
used or adapted to assess potential harm in six studies [48,
50, 51, 54–56]. Tools based on actual patient outcomes
may have practical limitations if a researcher becomes
aware of any errors as they occur and may be ethically
obliged to intervene, or in retrospective studies where it
may be difficult to identify any clinical effects because of
the delay between the occurrence and identification of
errors [11]. The main benefit of using potential outcomes is
that even in the absence of actual patient harm, judgments
can be made about severity; however, assessing potential
outcomes is likely to be more subjective.
3.4 Severity Levels
Tools varied in the number and range of severity levels
assessed. The number of levels of severity ranged from two
to continuous. The majority of tools included levels rang-
ing from potentially or actually lethal, to minor/mild error,
or no harm. However, some tools had ‘severe’ or ‘harmful’
as the highest level of severity and did not have a separate
category for life-threatening errors. In addition, Folli
et al.’s [16] lowest harm rating was ‘significant’. Some
authors [24–27] expanded the number of severity catego-
ries from Folli et al. [16] to include minor errors. Adding a
category could complicate the assessment for the review-
ers, but it allows for a wider range of responses, and
therefore potentially increases the sensitivity of the
method.
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3.5 Reliability
A measure of reliability was established for 17 (43 %)
tools (ESM Table 2) [9, 11, 15, 16, 24, 28, 31, 33, 34, 37–
39, 48, 50, 63, 67, 68]. In all cases this was inter-rater
reliability, which could be particularly important where
potential harm was being assessed. The Folli et al. [16]
scale appeared to have higher inter-rater reliability when
used to assess actual harm (j = 0.67–0.89 [16]) than
potential harm (j = 0.32–0.37 [17]). However, this finding
should be interpreted with caution as these were two sep-
arate studies using different assessors. High inter-rater
reliability (j[ 0.7) was found for five tools (ESM
Table 2): Folli adapted by Abdel-Qader et al. [24], Folli
adapted by Lesar et al. [28] in 1990, Kozer et al.’s 2002
tool [39], NCC MERP index adapted by Forrey et al. [48],
and Wang et al.’s tool [67]. It is of note that the NCC
MERP index was more reliable when collapsed into six
levels of severity than when all nine levels were used in the
same studies [48, 50]. Dean and Barber [11] used gener-
alizability theory to establish the reliability of their tool.
They found that in order to achieve an acceptable gener-
alizability coefficient ([0.8) four reviewers were required
and their mean score then used as the index of severity.
Fig. 1 Flow chart of papers identified, screened, and evaluated
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Subsequent studies measuring the severity of prescribing
errors using Dean and Barber’s tool [11] have used five
reviewers based on a conference abstract, which does not
meet this review’s inclusion criteria. There was no infor-
mation regarding reliability for 23 (57 %) tools [11, 25–27,
35, 40–42, 51–62, 64–66], and in seven cases (18 %)
descriptive information was given but no statistical infor-
mation presented [9, 15, 31, 33, 34, 37, 63].
3.6 Validity
Validity was only reported for five (12.5 %) tools [11, 48,
61] (ESM Table 2). These all explored construct or crite-
rion validity and measured raters’ judgments of potential
harm against actual harm in situations where the outcome
was known. Dean and Barber [11] found that there was a
clear relationship between potential harm as assessed using
their scales and actual harm. Forrey et al. [48] found that
the original NCC MERP index [68] had 74 % alignment
and that their adapted version had 81.0–83.9 % alignment
when potential harm assessment was compared with actual
harm. Ridley et al. [61] reported that there was no rela-
tionship between potential harm and apparent actual harm.
3.7 Acceptability
Very little information was given on acceptability or ease
of use of the tools. However, Dean and Barber’s tool [11]
requires four reviewers to rate error severity in order to
achieve acceptable reliability, which could potentially be
viewed as time consuming and a disadvantage of that
particular tool.
3.8 Comparison with Studies Measuring Medication
Administration Errors
Our findings are similar to those for studies of adminis-
tration errors. In our review, 43 % of studies of prescribing
error prevalence did not include assessment of severity. Of
those that did, 67 % used previously established methods
and 33 % used their own tools. In a review of studies of the
prevalence of administration errors, Keers et al. [70] found
that 44 % of 91 studies did not attempt to determine the
clinical significance of identified administration errors and
that whilst 82 % of these studies used previously published
severity tools, 18 % used their own criteria.
3.9 Review Limitations
Our search strategy excluded studies not published in Eng-
lish and focused on the hospital setting. We based our work
on a previous paper and an existing search strategy rather
than developing our own. However, this strategy was a
sufficiently close fit to match our needs. We acknowledge
that one of the authors of this review, BDF, was the author of
one of the tools [11], giving a potential source of bias. One of
the databases that we searched was not publically available,
but our own local database of medication error studies.
3.10 Recommendations
Researchers and clinicians may have different needs in
relation to a tool for assessing the severity of medication
errors. However, in general, an ideal tool should be specific
to medication error severity, relatively easy and not too time
consuming to use, reliable, and validated in different
healthcare systems. Few studies presented information on
ease of use or the time required. We identified only two
tools with acceptable validity and reliability: the NCC
MERP index as adapted by Forrey et al. [48], and Dean and
Barber’s tool [11]. It is not possible to directly compare the
reliability of the two tools as they used different methods of
assessing reliability. However, information about their
development and ease of use is limited and Dean and Bar-
ber’s tool [11] may be more time consuming to use. Forrey
et al.’s tool [48] is a mixture of error identification and error
severity. Currently, the most appropriate instrument will
need to be selected based on use. Forrey et al.’s tool may be
most appropriate for use in clinical practice as it is less time
consuming to use. However, Dean and Barber’s tool may be
better for research as it has been tested on a larger sample
size and the continuous scale potentially permits more
powerful statistical analysis in comparative studies. There is
also scope for developing and testing of a new tool which
meets all of the criteria above. Due to the wide range of
tools used in the literature, researchers should also consider
developing a basis of comparison between tools to assist in
comparing findings across studies.
4 Conclusion
When assessing the effects of interventions on prescribing
error rates, the severity of error should also be considered
[5, 6]. When selecting a tool to assess prescribing error
severity, its development, reliability, validity, and ease of
use need to be taken into account. There is potentially the
need to establish a less time-consuming method of mea-
suring severity of prescribing errors, with acceptable
international reliability and validity. Due to the wide range
of tools used, developing a basis of comparison between
tools would potentially be helpful in comparing findings
across studies.
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Appendix: Search Strategy EMBASE
1. medication error/ or prescribing error.mp.
2. near miss.mp.
3. adverse drug reaction/ or adverse event.mp.
4. error preventable.mp.
5. prescription/ or prescribe.mp. or prescription.mp.
6. incidence/ or incidence.mp.
7. prevalence.mp. or prevalence/
8. epidemiology/ or epidemiology.mp
9. rate.mp.
10. hospitalization/ or hospitalization.mp
11. hospital/
12. in patients.mp. or hospital patient/
13. 1 or 2 or 3 or 4
14. 6 or 7 or 8 or 9
15. 10 or 11 or 12
16. 5 and 13 and 14 and 15
17. 16 and 2008:2013 (sa year).
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